20% higher D30 engagement from new features launched September 22, 2025 is based on a pre-post analysis from August 22 to October 24, 2025 of D30 engagement in key in-app behaviours (completing any Home Screen Task, tapping the Bank button to bank rewards for steps, viewing the Health Report, logging medication, or reading an article)
Research shows it can improve memory, attention, and focus, particularly for those experiencing age-related cognitive decline
Sexual Function Research Studies investigated Melanotan-II for erectile dysfunction, leading to the development of the derivative drug bremelanotide (PT-141), which specifically targets sexual function through MC4R
These gastrointestinal effects often diminish over time but can be significant for some users